News articles

News article list

• Green light for groundbreaking personalised cancer therapy that reprogrammes immune system

  We've recommended an innovative one-off cell therapy that could give hundreds of lymphoma patients precious extra time with loved ones.

• NICE joins international collaboration on HTA methods research

  We’ve partnered with the USA-based Institute for Clinical and Economic Review (ICER) and the Canadian Drug Agency (CDA-AMC) to establish the Health Economics Methods Advisory (HEMA), a new international initiative to research and evaluate health technology assessment (HTA) methods.

• NICE announces proposals to transform its HealthTech programme to drive more technology into the NHS

  Consultation launches on the biggest shake-up of NICE's HealthTech programme to date.

• NICE approves groundbreaking one-off gene therapy for severe sickle cell disease

  People in England with severe sickle cell disease will be among the first to receive treatment using revolutionary CRISPR gene editing technology, following publication of our final draft guidance today.

• Thousands of people with a severe dust mite allergy are set to benefit from life-changing treatment

  We've recommended an innovative daily tablet treatment shown to reduce symptoms and improve quality of life.

• Healthcare professionals advised to ask people about gambling at health checks and GP appointments

  The recommendation is included in our first clinical guideline on gambling-related harms: identification, assessment and management.